醫生你好這是我媽咪那時候的病理報告 NOMED 28000-B-M8140329000-B-M09450 DX Lung right middle lobe wedge resection ----- Invasive acinar adenocarcinoma moderately differentiated G2 AJCC 8TH Pathological stage IA1 pT1a Nx also referring to S202292488 Pleura right middle lobe wedge resection ----- Negative for malignancy GROSS D The specimen consists of a wedge resection of right middle lung measuring 3.0 x 2.2 x 1.5 cm and weighing 2.7 gm. The surface shows focal retraction and fibrosis. It had been open and a tumor measuring 0.6 x 0.3 x 0.3 cm located at 0.6 cm beneath the pleura and 0.6 cm from resection ends. The tumor is ill-defined and appears whitish and solid. All for sections and labeled as 1 tumor 2-3 non-tumor lung tissue. MICRO D Procedure Wedge resection Synchronous Tumors Not applicable Tumor Site Right middle lobe Tumor Size also referring to S202292488 Total tumor size 1.0 x 0.8 x 0.6 cm Invasive tumor size 0.8 x 0.6 x 0.6 cm Tumor Focality Single focus Histologic Type Invasive acinar adenocarcinoma Percentage of each components Lepidic 40  Acinar 60  Histologic Grade Moderately differentiated G2 Margin All margins negative for invasive carcinoma Distance of invasive carcinoma from closest margin 0.6 cm Specify closest margin parenchymal resection margin Direct invasion of adjacent structures Not applicable No adjacent structures present Visceral pleural invasion The tumor does not invade the visceral pleura PL0. Lymphovascular invasion Not identified Perinerual invasion Not identified Spread through air spaces STAS Not identified MICRO DCont Treatment Effect No known presurgical treatment Lymph node No lymph node submitted Non-tumor Parenchyma The non-tumorous parenchyma does not show significant pathological change. Pathologic Stagining pTNM Primary tumor pT pT1a Tumor ＜1 cm or less in greatest dimension Regional lymph node pN pN not assigned no nodes submitted or found Distant metastasis pM Not applicable - pM cannot be determined from the submitted specimens Pathological stage IA1 pT1a Nx AJCC 8th Additional pathological findings Lymphocytic infiltration 打字員：病理醫師：李沛航 尚有報告： 病解專醫字：第0610 號 今年的CT Indication lung ca sp lobectomy for follow-up study This imaging study has been compared with previous CT on 20230612. Chest CT without and with IV contrast enhancement study shows Techniques From lower neck to diaphragmatic level in 3-mm contiguous section for preenhanced and enhanced CT Coronal 3mm and sagittal 5mm reconstruction performed Imaging findings sp RML wedge resection. Stable tiny RUL RML RLL nodules ＜3mm Blebs up to 14mm in the both lung No definite pneumothorax. No definite pleural effusion. No definite pericardial effusion. No definite enlargement of mediastinal LNs. No definite adrenal mass. No definite enlarged lymph nodes noted in the upper retroperitoneum Impression  sp RML wedge resection  Stable tiny RUL RML RLL nodules ＜3mm 但公司健康檢查加做 CEA 1.56   每次回診都有做都正常 CA-125 25.7 CA153 12.3 CA199 12.3 Cyfea21-1 4.11 大於標準3.3 第一次測 原本醫生預計10月回診，請問我該先帶我媽咪回門診嗎 會是復發嗎，好擔心請你幫我解惑，謝謝
黃科家／27歲／男 就信中看來 1. 肺癌第一期 2. Cyfea21-1 4.11 大於標準3.3 第一次測 2.1 可以提早做細胞角質素21-1 Cyfra21-1追蹤，自費，所以你們隔一個月，或2-3個月再抽，如果升高，可以提前門診， 2.2 當然健保卡不會說你不能現在去看診， 祝平安喜樂 桃園醫院   陳斯榮